insights_auto
Why is ORX down 3,34%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,45 SEK
arrow_downward
-3,34%(-0,050) 1D
4-ноя., 17:29:47 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,51 SEK
High
1,65 SEK
Low
1,30 SEK
Mkt. cap
50,80 млн
Avg. vol.
280,57 миң
Volume
801,10 миң
P/E ratio
0,07
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,51 SEK
High
1,65 SEK
Low
1,30 SEK
Mkt. cap
50,80 млн
Avg. vol.
280,57 миң
Volume
801,10 миң
P/E ratio
0,07
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Virginia Business
·
51 мүнөт мурун
Accendra Health could be delisted by NYSE
MarketWatch
·
11 мүнөт мурун
Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress
Yahoo Finance
·
35 мүнөт мурун
The Nasdaq-100 Is Outperforming Nvidia, Microsoft, Amazon, Meta Platforms, Alphabet, and Tesla This Year. Here's My Favorite Low-Cost ETF to Buy the Dip.
The Washington Post
·
2 саат мурун
The S&P 500 climbs after Democrats sweep the midterms
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteorexo.com